Utah Medical Products Price to Sales Ratio 2010-2025 | UTMD
Historical PS ratio values for Utah Medical Products (UTMD) over the last 10 years. The current P/S ratio for Utah Medical Products as of June 20, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Utah Medical Products P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-06-20 | 53.64 | 4.72 | |
| 2025-03-31 | 55.73 | $11.37 | 4.90 |
| 2024-12-31 | 60.80 | $11.57 | 5.26 |
| 2024-09-30 | 65.86 | $12.35 | 5.33 |
| 2024-06-30 | 65.48 | $12.91 | 5.07 |
| 2024-03-31 | 69.38 | $13.50 | 5.14 |
| 2023-12-31 | 81.82 | $13.81 | 5.93 |
| 2023-09-30 | 83.25 | $14.14 | 5.89 |
| 2023-06-30 | 89.91 | $14.27 | 6.30 |
| 2023-03-31 | 91.14 | $14.41 | 6.32 |
| 2022-12-31 | 96.37 | $14.33 | 6.72 |
| 2022-09-30 | 81.53 | $14.13 | 5.77 |
| 2022-06-30 | 81.82 | $14.01 | 5.84 |
| 2022-03-31 | 85.30 | $13.78 | 6.19 |
| 2021-12-31 | 94.61 | $13.41 | 7.05 |
| 2021-09-30 | 86.25 | $13.16 | 6.56 |
| 2021-06-30 | 78.76 | $12.59 | 6.26 |
| 2021-03-31 | 79.93 | $11.54 | 6.93 |
| 2020-12-31 | 77.57 | $11.47 | 6.76 |
| 2020-09-30 | 73.26 | $11.36 | 6.45 |
| 2020-06-30 | 81.00 | $11.84 | 6.84 |
| 2020-03-31 | 85.71 | $12.61 | 6.80 |
| 2019-12-31 | 98.02 | $12.55 | 7.81 |
| 2019-09-30 | 86.83 | $11.99 | 7.24 |
| 2019-06-30 | 86.46 | $11.41 | 7.57 |
| 2019-03-31 | 79.46 | $11.16 | 7.12 |
| 2018-12-31 | 74.56 | $11.20 | 6.66 |
| 2018-09-30 | 84.28 | $11.32 | 7.44 |
| 2018-06-30 | 98.27 | $11.26 | 8.72 |
| 2018-03-31 | 87.96 | $11.24 | 7.82 |
| 2017-12-31 | 72.22 | $11.09 | 6.51 |
| 2017-09-30 | 65.04 | $10.71 | 6.07 |
| 2017-06-30 | 63.79 | $10.56 | 6.04 |
| 2017-03-31 | 54.68 | $10.44 | 5.24 |
| 2016-12-31 | 63.58 | $10.42 | 6.10 |
| 2016-09-30 | 52.06 | $10.61 | 4.91 |
| 2016-06-30 | 54.62 | $10.69 | 5.11 |
| 2016-03-31 | 54.00 | $10.67 | 5.06 |
| 2015-12-31 | 50.33 | $10.65 | 4.73 |
| 2015-09-30 | 46.10 | $10.82 | 4.26 |
| 2015-06-30 | 50.79 | $11.03 | 4.61 |
| 2015-03-31 | 50.75 | $11.05 | 4.59 |
| 2014-12-31 | 50.69 | $10.94 | 4.64 |
| 2014-09-30 | 40.98 | $10.89 | 3.76 |
| 2014-06-30 | 43.02 | $10.70 | 4.02 |
| 2014-03-31 | 48.13 | $10.57 | 4.55 |
| 2013-12-31 | 47.36 | $10.74 | 4.41 |
| 2013-09-30 | 48.99 | $10.72 | 4.57 |
| 2013-06-30 | 44.54 | $10.88 | 4.09 |
| 2013-03-31 | 39.80 | $10.93 | 3.64 |
| 2012-12-31 | 29.27 | $11.22 | 2.61 |
| 2012-09-30 | 27.40 | $11.28 | 2.43 |
| 2012-06-30 | 26.84 | $11.43 | 2.35 |
| 2012-03-31 | 24.72 | $11.57 | 2.14 |
| 2011-12-31 | 21.29 | $10.39 | 2.05 |
| 2011-09-30 | 20.70 | $9.38 | 2.21 |
| 2011-06-30 | 20.34 | $8.13 | 2.50 |
| 2011-03-31 | 22.19 | $7.00 | 3.17 |
| 2010-12-31 | 20.45 | $6.90 | 2.97 |
| 2010-09-30 | 21.52 | $6.98 | 3.08 |
| 2010-06-30 | 18.18 | $7.11 | 2.56 |
| 2010-03-31 | 20.34 | $7.13 | 2.85 |
| 2009-12-31 | 21.03 | $7.15 | 2.94 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.174B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.381B | 27.82 |
| Boston Scientific (BSX) | United States | $149.868B | 37.52 |
| Stryker (SYK) | United States | $143.347B | 29.97 |
| EssilorLuxottica (ESLOY) | France | $128.152B | 0.00 |
| Medtronic (MDT) | Ireland | $110.735B | 15.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.273B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.811B | 26.69 |
| ResMed (RMD) | United States | $37.196B | 27.94 |
| Agilent Technologies (A) | United States | $32.827B | 21.40 |
| GE HealthCare Technologies (GEHC) | United States | $32.638B | 15.50 |
| Terumo (TRUMY) | Japan | $26.398B | 34.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.463B | 15.06 |
| Insulet (PODD) | United States | $21.334B | 83.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.048B | 11.59 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.627B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.442B | 22.42 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $4.123B | 18.42 |
| Perrigo (PRGO) | Ireland | $3.643B | 9.23 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.415B | 15.55 |
| Envista Holdings (NVST) | United States | $3.202B | 26.61 |
| ICU Medical (ICUI) | United States | $3.144B | 23.18 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.848B | 41.30 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.324B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.132B | 11.49 |
| Neogen (NEOG) | United States | $1.072B | 13.72 |
| Green Thumb Industries (GTBIF) | United States | $1.042B | 23.43 |
| BioLife Solutions (BLFS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.37 |
| InMode (INMD) | Israel | $0.839B | 8.46 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Owens & Minor (OMI) | United States | $0.567B | 4.71 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Valneva SE (VALN) | France | $0.478B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.377B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.362B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.319B | 11.74 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.13 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 68.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.217B | 6.09 |
| Cresco Labs (CRLBF) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.206B | 54.55 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.34 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.053B | 71.43 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |